Provided by Tiger Trade Technology Pte. Ltd.

Labcorp Holdings Inc

304.60
-3.5100-1.14%
Pre-market: 305.000.4000+0.13%07:39 EDT
Volume:559.55K
Turnover:171.14M
Market Cap:24.64B
PE:25.22
High:309.72
Open:306.00
Low:304.06
Close:308.11
52wk High:341.80
52wk Low:244.52
Shares:80.90M
Float Shares:80.50M
Volume Ratio:0.77
T/O Rate:0.70%
Dividend:2.88
Dividend Rate:0.95%
EPS(TTM):12.08
EPS(LYR):10.46
ROE:11.73%
ROA:5.53%
PB:2.86
PE(LYR):29.12

Loading ...

Labcorp Holdings is Maintained at Neutral by Piper Sandler

Dow Jones
·
Aug 04

Piper Sandler Adjusts Price Target on Labcorp Holdings to $309 From $300, Maintains Neutral Rating

MT Newswires Live
·
Aug 04

Labcorp Launches FDA-Approved Pten Companion Diagnostic for Prostate Cancer

THOMSON REUTERS
·
Aug 04

Labcorp : JP Morgan Raises Target Price to $360 from $330

THOMSON REUTERS
·
Aug 03

UBS Remains a Buy on Labcorp Holdings (LH)

TIPRANKS
·
Jul 31

Labcorp Holdings is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 31

Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 31

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

Reuters
·
Jul 31

CareDx Q2 Revenue Beats Estimates; Outlook Lifted

Reuters
·
Jul 31

Barclays Raises Labcorp Price Target to $320 From $290, Maintains Equalweight Rating

MT Newswires Live
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30

Labcorp Releases Transcript of Q2 2026 Earnings Call Webcast Prepared Remarks

Reuters
·
Jul 30

Labcorp Exec Says Specialty Testing Business Continues to Grow Faster than Routine Testing Business, Expects Trend to Continue - Conf Call

THOMSON REUTERS
·
Jul 30

Labcorp Exec Says Oncology Patients Tend to Receive Significantly More Tests over Time than Typical Patients, Driving Higher Tests Per Accession - Conf Call

THOMSON REUTERS
·
Jul 30

Labcorp Exec Says Assumption for About 30 Basis Points Impact to 2026 Diagnostics Volume from Aca-Related Changes Remains Appropriate - Conf Call

THOMSON REUTERS
·
Jul 30

Stock Track | Labcorp Holdings Plunges 5.43% in Pre-market as Diagnostics Revenue Miss Weighs on Strong Q2 Results

Stock Track
·
Jul 30

Labcorp Raises Annual Profit Forecast on Strong Testing Demand

Reuters
·
Jul 30

Labcorp Lifts Outlook as 2Q Profit, Revenue Rise

Dow Jones
·
Jul 30

Labcorp reports Q2 adjusted EPS $4.99, consensus $4.77

TIPRANKS
·
Jul 30

Labcorp FY26 Q2 Diluted EPS Rises 28.5% to $3.64; Revenue Increases 5.8% to $3.73 Billion

Reuters
·
Jul 30